Dr. Gary S. Guthart Net Worth

The estimated Net Worth of Gary S Guthart is at least $42.5 Milion dollars as of 30 July 2024. Dr Guthart owns over 30,828 units of Intuitive Surgical Inc stock worth over $11,605,585 and over the last 21 years he sold ISRG stock worth over $30,099,604. In addition, he makes $822,975 as Pres i CEO & Director at Intuitive Surgical Inc.

Dr Guthart ISRG stock SEC Form 4 insiders trading

Dr has made over 71 trades of the Intuitive Surgical Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 30,828 units of ISRG stock worth $13,674,068 on 30 July 2024.

The largest trade he's ever made was exercising 126,000 units of Intuitive Surgical Inc stock on 26 July 2022 worth over $7,242,480. On average, Dr trades about 9,762 units every 59 days since 2004. As of 30 July 2024 he still owns at least 23,640 units of Intuitive Surgical Inc stock.

You can see the complete history of Dr Guthart stock trades at the bottom of the page.

Dr. Gary S. Guthart biography

Dr. Gary S. Guthart is the Pres, CEO & Director at Intuitive Surgical Inc.

What is the salary of Dr Guthart?

As the Pres i CEO & Director of Intuitive Surgical Inc, the total compensation of Dr Guthart at Intuitive Surgical Inc is $822,975. There are no executives at Intuitive Surgical Inc getting paid more.

How old is Dr Guthart?

Dr Guthart is 55, he's been the Pres i CEO & Director of Intuitive Surgical Inc since . There are 4 older and 2 younger executives at Intuitive Surgical Inc. The oldest executive at Intuitive Surgical Inc is Julian Nikolchev, 66, who is the Sr. VP of Corp. Devel. & Strategy.

What's Dr Guthart's mailing address?

Gary's mailing address filed with the SEC is 1020, Kifer Road, Sunnyvale, Santa Clara County, California, 94086, United States.

Insiders trading at Intuitive Surgical Inc

Over the last 21 years, insiders at Intuitive Surgical Inc have traded over $322,763,518 worth of Intuitive Surgical Inc stock. The most active insiders traders include Robert W Duggan, Gary S Guthart oraz Susan K Barnes. On average, Intuitive Surgical Inc executives and independent directors trade stock every 10 days with the average trade being worth of $3,589,680. The most recent stock trade was executed by Robert De Santis on 10 September 2024, trading 238 units of ISRG stock currently worth $63,553.

What does Intuitive Surgical Inc do?

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.

Complete history of Dr Guthart stock trades at Illumina Inc i Intuitive Surgical Inc

Intuitive Surgical Inc executives and stock owners

Intuitive Surgical Inc executives and other stock owners filed with the SEC include:

• Dr. Gary S. Guthart,
  Pres, CEO & Director
• David J. Rosa,
  Exec. VP and Chief Strategy & Growth Officer
• Marshall L. Mohr,
  Exec. VP of Global Bus. Services
• Dr. Myriam J. Curet McAdams F.A.C.S., M.D.,
  Exec. VP & Chief Medical Officer
• Robert DeSantis,
  Exec. VP & Chief Product Officer
• Philip Kim,
  Head of Investor Relations
• Fredrik Widman,
  VP, Principal Accounting Officer & Corp. Controller
• Craig Child,
  Sr. VP of HR
• Julian Nikolchev,
  Sr. VP of Corp. Devel. & Strategy
• Kara Andersen Reiter,
  Sr. VP, Gen. Counsel & Chief Compliance Officer
• Calvin Darling,
  Sr. Director of IR
• Jamie E. Samath,
  Chief Financial Officer
• Monica P Reed,
  Director
• David J. Rosa,
  President
• Brian Edward Miller,
  EVP & Chief Digital Officer
• Jami K Nachtsheim,
  Director
• Mark J Rubash,
  Director
• Alan J Levy,
  Director
• Mark J Meltzer,
  SVP & General Counsel
• Michael A Friedman,
  Director
• Craig H Barratt,
  Director
• Keith R Leonard,
  Director
• George Jr Stalk,
  Director
• Colin Morales,
  SVP Customer Support Group
• Amal M Johnson,
  
• Joseph C Beery,
  Director
• Don R Kania,
  Director
• Floyd D Md Loop,
  Director
• Reiter Kara Andersen,
  Sr VP General Counsel & CCO
• Jerome J Mcnamara,
  Sr. Vice President
• Augusto V. Castello,
  SVP Product Ops
• Myriam Curet,
  EVP & Chief Medical Officer
• Eric H Halvorson,
  Director
• Robert W Duggan,
  Director
• Richard J Kramer,
  Director
• D Keith Grossman,
  Director
• John F Jr Runkel,
  SR VICE PRESIDENT GEN. COUNSEL
• Benjamin B Gong,
  Vice President, Finance
• Eric Miller,
  Sr. Vice President
• William J Mercer,
  Director
• William Clark Meyers,
  Director
• Bennett Nussbaum,
  Director
• Richard Michael Epstein,
  Sr. Vice President, Marketing
• Susan K Barnes,
  CFO
• Frederic H Moll,
  Director
• Amy L Ladd,
  Director
• Salvatore Brogna,
  EVP & Chief Operating Officer
• Lonnie M Smith,
  Director
• Michele Di Martino,
  See Remarks
• Sreelakshmi Kolli,
  Director
• Lewis Chew,
  Director
• Robert De Santis,
  EVP & Chief Strategy & Corp Op
• Gary S Guthart,
  CEO
• Jamie Samath,
  Chief Financial Officer
• Henry L Charlton,
  SVP & Chief Commercial and Mkt
• Marshall Mohr,
  Executive VP Global Business S
• Gary Loeb,
  General Counsel
• Mark Brosius,
  SVP & Chief Mfg and Supply Cha